Previous studies demonstrated that treatment with BMSCs alone significantly increased the expression of angiogenin, MMP9 and ED‐1 in T1DM stroke rats, leading to the failure of BMSCs treatment against stroke.10, 26. This evidence concerns the gene MMP9 and stroke disorder.